Mather Group »

Rigel Pharmaceuticals shares owned by Mather Group

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Mather Group from 13F filings

Historical chart of Mather Group investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Mather Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Mather Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $666 450 1.48

More positions owned by Mather Group

Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Lennox International (LII)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Faln Angls Usd (FALN)
Dimensional Etf Trust Intl Small Cap E (DFIS)
Vanguard Scottsdale Fds Long Term Treas (VGLT)

View all positions for Mather Group

Top funds holding Rigel Pharmaceuticals

Northern Trust
Wellington Management Company
UBS O'Connor
FMR
UBS Group
Prudential Financial
Legal & General Group
Barclays
Flagship Harbor Advisors
Advisor Group Holdings
IFP Advisors
Ronald Blue Trust
Mather Group
Nelson, Van Denburg & Campbell Wealth Management
EverSource Wealth Advisors

View all funds holding Rigel Pharmaceuticals